Search

Bitemporal hemianopia typically results from compression of the optic chiasm by sellar, suprasellar, or chiasmal lesions. Most of the cases of bitemporal hemianopia are secondary to pituitary masses. Defects in the temporal half of the visual field that mimic those that are caused by such pituitary or chiasmal lesions are known as bitemporal “pseudohemianopia” and involve orbital pathology. Tilted disc syndrome is an eye anomaly that may result in bitemporal visual field deficits similar to those that are caused by extrinsic or intrinsic mass effect on the optic chiasm. We report an incidentally found tilted disc syndrome in a patient with a history of surgically treated high myopia and the symptoms of  bilateral, gradual vision loss.

Background: Portal vein thrombosis (PVT) is a rare but severe entity that can cause clinically significant sequela such as worsening portal hypertension or mesenteric ischemia. Those cases refractory to medical management may be referred for endovascular intervention. Several technical considerations have been described in the literature, but a cohesive comparison of these multiple techniques is lacking., Methods: The purpose of this article is to review the diagnosis and endovascular management of PVT, including areas in which further research is warranted., Results: Cases of PVT can be readily diagnosed using ultrasound, computed tomography, or magnetic resonance imaging. Treatment often begins with systemic anticoagulation and endovascular interventions may be used in selected cases. Determining the optimal approach to accessing the portal venous system depends on the underlying disease and chronicity of the thrombus and the degree of occlusion. Once access to the portal venous system is established, catheter-directed therapy may be performed to achieve recanalization., Conclusion: Despite the heterogeneity in patient presentation, cases of PVT can be readily diagnosed across several imaging modalities. Strategizing interventional approaches involves evaluation of the underlying disease and the chronicity of the thrombus., Key Points: · This review will enable interventionalists to establish a framework for treating portal vein thrombosis by identifying patient risk factors and thrombus characteristics that determine patient management.. · The unique risks and benefits for transhepatic, transsplenic, and transmesenteric approaches for establishing portal venous access will be discussed.. · Advantages and complications of thrombolysis, thrombectomy, and transjugular intrahepatic portosystemic shunt creation for treating portal vein thrombosis will be reviewed in detail based on our extensive institutional experience.., Citation Format: · Ju C, Li X, Gadani S et al. Portal Vein Thrombosis: Diagnosis and Endovascular Management. Fortschr Röntgenstr 2022; 194: 169 - 180., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)